|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 47/50 | (2017.01) |
| A61P 35/00 | (2006.01) | ||
| A61K 47/68 | (2017.01) |
| (11) | Number of the document | 3134125 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15720314.2 |
| Date of filing the European patent application | 2015-04-27 | |
| (97) | Date of publication of the European application | 2017-03-01 |
| (45) | Date of publication and mention of the grant of the patent | 2019-10-09 |
| (46) | Date of publication of the claims translation | 2020-01-10 |
| (86) | Number | PCT/EP2015/059052 |
| Date | 2015-04-27 |
| (87) | Number | WO 2015/162293 |
| Date | 2015-10-29 |
| (30) | Number | Date | Country code |
| 14305621 | 2014-04-25 | EP |
| (72) |
RILATT, Ian, FR
PEREZ, Michel, FR
GOETSCH, Liliane, FR
BROUSSAS, Matthieu, FR
BEAU-LARVOR, Charlotte, FR
HAEUW, Jean-Franēois, FR
LAMOTHE, Marie, FR
|
| (73) |
Pierre Fabre Médicament,
45, Place Abel Gance, 92100 Boulogne-Billancourt,
FR
|
| (74) |
Aurelija ŠIDLAUSKIENĖ,
Dr. V. Šidlauskas ir partneriai, UAB, K. Būgos g. 29, LT-44326 Kaunas,
LT
|
| (54) | Antikūno ir vaisto konjugatas bei jo panaudojimas vėžio gydymui |
| ANTIBODY-DRUG-CONJUGATE AND ITS USE FOR THE TREATMENT OF CANCER |
| Payment date | Validity (years) | Amount | |
| 2026-03-24 | 12 | 289.00 EUR |
| 2027-04-27 |